Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

  1. García-Gutiérrez, V.
  2. Martinez-Trillos, A.
  3. Lopez Lorenzo, J.L.
  4. Bautista, G.
  5. Martin Mateos, M.L.
  6. Alvarez-Larrán, A.
  7. Iglesias Pérez, A.
  8. Romo Collado, A.
  9. Fernandez, A.
  10. Portero, A.
  11. Cuevas, B.
  12. Ruiz, C.
  13. Romero, E.
  14. Ortega, F.
  15. Mata, I.
  16. Tallón, J.
  17. García Garay, M.del..C.
  18. Ramirez Sánchez, M.J.
  19. de las Heras, N.
  20. Giraldo, P.
  21. Bobillo, S.
  22. Guinea, J.M.
  23. Deben, G.
  24. Valencia, S.
  25. Sebrango, A.
  26. Boqué, C.
  27. Maestro, B.
  28. Steegmann, J.L.
  29. Show all authors +
Journal:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Year of publication: 2015

Volume: 90

Issue: 5

Pages: 429-433

Type: Article

DOI: 10.1002/AJH.23973 GOOGLE SCHOLAR

Sustainable development goals